[1] 乔树宾.冠心病诊疗进展[M].北京:人民卫生出版社,2013:53-56.
[2] 史载祥,黄春林,史大卓.现代中医心血管病学[M].北京:人民卫生出版社.2006:1-2.
[3] Giulio G, Stefanini M.D, David R, et al. Drug-eluting coronary-artery stents [J]. New England Journal of Medicine, 2013, 368(3): 254-265.
[4] Sellke FW, Simons M. Angiogenesis in cardiovascular disease: Current status and therapeutic potential [J].Drugs, 1999, 58(3):391-396.
[5] 李敏,王硕仁,赵明镜,等. 活血、益气方药对心梗后心衰大鼠血流动力学影响的实验研究[J]. 中国中医基础医学杂志,2001,7(6):22-24.
[6] 王振涛,王硕仁,赵明镜,等. 活血和益气方药对心肌梗死后左心衰大鼠左心室重构影响的比较研究[J]. 中国中西医结合杂志,2002,22(5): 376-378.
[7] 张冬梅,吴爱明,娄利霞,等. 活血益气方对心梗后大鼠缺血心肌血管新生及VEGF表达的影响[J]. 辽宁中医杂志,2010,37(8): 1602-1604.
[8] Wakioka T,Sasaki A,Kato R,et al.Spred is a Sprouty-related suppressor of Ras signalling[J].Nature,2001,412(6847):647-651.
[9] Chong H, Vikis HG, Guan KL. Mechanisms of regulating theRaf kinase family [J]. Cellular signalling, 2003, 15(5): 463-469.
[10] Nicoli S, Standley C, Walker P, et al. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis[J]. Nature, 2010, 464(7292): 1196-1200.
[11] 刘振,刘玲玲,杨廷桐.两种大鼠心肌梗死模型的比较研究[J].动物医学进展,2010,31(4):19-25.
[12] Weidner N,Semple JP,Welch WR,et al. Tumor angiogenesis and metastasis——correlation in invasive breast carcinoma[J].The New England journal of medicine,1991,324(1):1-8.
[13] Ware JA,Simons M. Angiogenesis in ischemic heart disease [J]. Nature Med,1997,3(2): 158-164.
[14] Isner JM,Rosenfield K,Losordo DW,et al. Percutaneous intravascular US as adjunct to catheter-based interventions: preliminary experience in patients with peripheral vascular disease [J]. Radiology,1990,175(1): 61-70.
[15] Majchrzak K,Kaspera W,Szyma J,et al. Markers of angiogenesis(CD31, CD34, rCBV)and their prognostic value in low-grade gliomas [J]. Neurologiai Neurochirurgia Polska,2013,47(4): 325-331.
[16] Sharma B,Singh N,Gupta N,et al. Diagnostic modalities of precancerous and cancerous cervical lesions with special emphasis on CD31 angiogenesis factor as a marker [J]. Pathology research international,2013: 243168.
[17] Hamzah J,Jugold M,Kiessling F,et al. Vascular normalization in Rgs5-deficientTumors promote immune destruction [J]. Nature,2008,453(7193): 410-414.
[18] De La Cruz JP,Gonzalez-Correa JA,Guerrero A,et al. Pharmacological approach to Diabetic retinopathy. [J]. Diabetes Metab Res Rev,2004,20(2): 91-113.
[19] Patrick S Ward,Craig B Thompson. Metabolic Reprogramming: A Cancer Hallmark Even War burg Did Not Anticipate[J].Cancer cell,2012,20(3):297-308.
[20] Hlatky L,Hahnfeldt P,Folkman J. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us[J]. Journal of the National Cancer Institute,2002,94(12): 883-893.
[21] Banopadhyay R,Ort e C, Lawrenson JG, et al. Contractile proteins in pericytes at the blood-brain and blood-retinal barriers [J]. J Neurocytol, 2001, 30(1): 35-44.
[22] Nakano M, Atobe Y, Goris RC, et al. Ultrastructure of the capillary pericytes and the Expression of smooth muscle alpha-actin and desmin in the snake infrared sensory organs[J].The Anatomical Record, 2000, 260(3): 299-307.
[23] 王医术,李玉林,王心蕊,等.用α-SMA结合部位标记新生血管周细胞[J].吉林大学学报,2003,29(5):594-598.
[24] 于德新,张宗利,马祥兴,等. 血管生成及其成熟度在肝细胞癌边缘与中心的差异研究[J]. 中国现代普通外科进展,2009,12(2):113-117.
[25] 滕建英,郭瑞,谢菁,等.血管内皮生长因子DNA质粒对真皮支架修复猪Ⅲ度烧伤创面中血管化的影响[J].中华医学杂志,2011,91(36):2568-2872.
[26] 张静,王华,王立生. Spred的结构及生物学特性[J]. 军事医学科学院院刊,2009,33(1):74-77.
[27] Jiang ZY,He Z,King BL,et al. Characterization of multiple signaling pathways of insulin in the regulation of vascular endothelial growth factor expression in vascular cells and angiogenesis[J].The Journal of biological chemistry,2003,278(34):31964-31971.
[28] Wang S,Aurora AB,Johnson BA,et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis[J].Developmental Cell,2008,15(2): 261-271.
[29] Jakob P,Doerries C,Briand S,et al. Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity[J]. Circulation,2012,126(25):2962-2975.